# Acetazolamide for Obstructive Sleep Apnea to Improve Heart Health

> **NCT05616260** · PHASE2 · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 54 (actual)

## Conditions studied

- Obstructive Sleep Apnea

## Interventions

- **DRUG:** Acetazolamide
- **DRUG:** Placebo
- **DEVICE:** Continuous Positive Airway Pressure

## Key facts

- **NCT ID:** NCT05616260
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-02
- **Primary completion:** 2025-05-13
- **Final completion:** 2025-05-13
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2025-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05616260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05616260, "Acetazolamide for Obstructive Sleep Apnea to Improve Heart Health". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05616260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*